Incorrect Byline and Figure Terminology: Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial

Michelle L. O'Donoghue, Eugene Braunwald, Harvey D. White, Dylan P. Steen, Mary Ann Lukas, Elizabeth Tarka, P. Gabriel Steg, Judith S. Hochman, Christoph Bode, Aldo P. Maggioni, Kyung Ah Im, Jennifer B. Shannon, Richard Y. Davies, Sabina A. Murphy, Sharon E. Crugnale, Stephen D. Wiviott, Marc P. Bonaca, David F Watson, W. Douglas Weaver, Patrick W. SerruysChristopher P. Cannon, SOLID-TIMI 52 Investigators, P. E. Aylward, S. A. Chen, B. Lewis, J. Anderson, M. Freeman, R. Lehman, P. Roberts-Thomson, M. Nguyen, X. Li, D. Weber, J. Elliott, N. Harrison, R. Stewart, Y. K. Wong, A. Ahmed, S. Ahmed, J. Anderson, S. Baker, J. Chin, R. Foreman, D. Lee, P. Morris, A. Smith, J. Thomas, D. Wilson

    Research output: Contribution to journalComment/debate

    6 Citations (Scopus)

    Abstract

    In the Original Investigation entitled “Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: the SOLID-TIMI 52 Randomized Clinical Trial” published in the September 10, 2014, issue of JAMA (2014;312[10]:1006-1015. doi:10.1001/jama.2014.11061), there were 2 errors. In the byline, the name of the fourth author should have been “Dylan L. Steen, MD.” The title of Figure 2 should have been “Primary End Point of the SOLID-TIMI 52 Trial” and the first sentence of the figure legend should have been “Cumulative incidence curves for the primary end point.” This article was corrected online.

    Original languageEnglish
    Pages (from-to)1473
    Number of pages1
    JournalJAMA - Journal of the American Medical Association
    Volume312
    Issue number14
    DOIs
    Publication statusPublished - 8 Oct 2014

    Keywords

    • Darapladib
    • acute coronary syndrome
    • atherogenesis
    • Lipoprotein-associated phospholipase A2 (Lp-PLA2)
    • Lp-PLA2 enzyme
    • Erratum

    Fingerprint Dive into the research topics of 'Incorrect Byline and Figure Terminology: Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial'. Together they form a unique fingerprint.

    Cite this